The science field is exhilarating for those who love to unlock the secrets of the universe. As a society, we’ve traveled leaps and bounds in the fields of medicine and technology, and we’re on course to do so much more. However, the biggest hurdle that scientists face is securing funding for their research and development projects.
Scientists can’t do their incredible work without proper funding. If you understand the function of science in business, you know that science doesn’t pay unless scientists discover or create something of value to society. With that being the case, scientists rely heavily on grants and private money to complete their research and development projects. Continue reading to learn why startups in the science sector depend on grants and private money for their work.
There are a lot of moving parts in scientific research.
You’ve probably seen shots and video clips of scientists hard at work in a lab working with different strains of viruses and fungi to create a vaccine. What you don’t see is all of the labor that goes into producing and delivering the materials scientists need for their work.
There are labs for the cultivation of the various fungi, mutant viral strains, and other organisms that serve various functions in research. Depending on what projects a startup on which a biotech company is working, they may outsource mutant strain cultivation and Trichoderma reesei expression services. Trichoderma reesei (T. reesei) is a fungus, specifically a filamentous fungi, which is cheap to grow in a laboratory with a minimal medium and can be used to produce strains of cellulase and recombinant protein. By outsourcing the cultivation of T. reesei as well as cellulase expression to other professionals, labs can save time, money, and resources.
Having so many contributing entities on a given project means that there are a lot of people to pay, from general laborers to scientists and executives. Not to mention, the more high-stakes a project is, the more expensive every aspect, from resources and lab equipment to personnel. A startup company undertaking a large project will most likely need private money and grants to cover the cost of paying everyone involved in a research project.
The more advanced technology becomes, the more expensive labs and equipment are.
As you probably expect, the ultra-high-tech equipment scientists use for their research and development projects is costly. When you’re dealing with sensitive organisms and filamentous fungi like T. reesei, cellulase, various culture supernatants, and the equipment to properly store it all, as well as the high resultant total protein concentration.
When startup companies launch, their first step is usually building or buying a laboratory. As you can imagine, building a laboratory is a bit more expensive than the average home. Private money lenders like Pacific Private Money provide startups with the funding they need to build their labs, which aside from the scientists themselves, is the most critical part of a scientific research company or biotech startup. To obtain private money, scientists have to explain the present study they’re proposing, and make clear the important role such funding would play in the modification of their facilities. Lenders like Pacific Private Money won’t go with just any borrowers, they need to understand that the present study will make a significant difference in the world. Sometimes lenders will request an additional file or further explanation before giving a green light.
Many venture capitalists see science as a promising field for investing.
Indeed, much of what scientific startups do is research. However, the results of their research often lead to advancements in medicine, technology, and manufacturing that change the world as we know it. Consider developments such as AI and different medicines for cancer, HIV, and COVID-19. All of those advancements are worth billions of dollars, and the lion’s share of the profits will go to the stakeholders.
For investors, the opportunity to get in at the ground level and play an important role in what could potentially be something huge is an enticing lure. People who invest in traditional assets like stocks usually only get to buy stock in a company after it’s already profitable. Because they’re investing later in the company’s journey, their stakes and dividends are smaller.
When private investors, hedge funds, and venture capitalists invest in companies, they often provide the funds that allow the company to get up and running. Therefore, their stakes and dividends from their investments are much larger because they contributed significantly to the startup’s growth.
Launching a startup science or tech company requires more capital than your average small business. Society as a whole owes a debt of gratitude to science startups and their investors for their great and many contributions to civilization.